Alma Fulurija
Corporate Officer/Principal bei Ondek Pty Ltd.
Profil
Alma Fulurija is currently the Head of Immunology & Translational Research at Ondek Pty Ltd.
She previously worked as a Principal at Cytos Biotechnology AG.
Aktive Positionen von Alma Fulurija
| Unternehmen | Position | Beginn |
|---|---|---|
Ondek Pty Ltd.
 Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Alma Fulurija
| Unternehmen | Position | Ende |
|---|---|---|
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Ondek Pty Ltd.
Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Health Technology |
